- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 12, 2025 | 40.86M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2025 | 37.08M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 27.31M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 23.96M sh |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $163.7K |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | −$33.14K |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −$200.4K |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | −$363.95K |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $3.23K |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $33.15K |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $3.23K |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $33.15K |
| Current Assets | Q2 2025 · Mar 31, 2025 | $166.93K |
| Current Assets | Q2 2025 · Sep 30, 2024 | $15 |
| Total Assets | Q2 2025 · Mar 31, 2025 | $166.93K |
| Total Assets | Q2 2025 · Sep 30, 2024 | $15 |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | −$0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | −$0.01 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.00 |
| Sga Expense | Q2 2025 · Mar 31, 2025 | $151.35K |
| Sga Expense | Q2 2025 · Mar 31, 2025 | $271.82K |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $3.89K |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $53.36K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$27.23K |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.00 |
| Net Income | Q2 2025 · Mar 31, 2024 | −$3.89K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$53.36K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$3.89K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$53.36K |